SmithKline Beecham reveals new chemokine receptor antagonists and their potential use Nov. 7, 2000 No Comments
News from ICACI 2000: IL-4/IL-5 inhibitor exerts beneficial effects in models of atopic dermatitis Oct. 31, 2000 No Comments
RXR-selective retinoids synthesized at Allergan for use in skin and other disorders Oct. 27, 2000 No Comments
At least 50% of patients experience clinical benefit with Vasogen's psoriasis candidate Oct. 20, 2000 No Comments
RSS